Spyre Therapeutics, Inc. (NASDAQ:SYRE) IPO

Spyre Therapeutics, Inc.

IPO

Went public as Aeglea BioTherapeutics, Inc. Priced at US$10.00 a share on Apr 6, 2016.

Price
US$10.00 a share
Shares offered
5,000,000 shares of common stock
Offering size
US$50 million
Underwriters' option
Up to 750,000 more shares
Underwriters
UBS Investment Bank, BMO Capital Markets, Wells Fargo Securities, Needham & Company · In the order on the cover
Shares delivered
On or about Apr 12, 2016

Steps

StepWhen
Draft sent to the SEC in confidenceMay 6, 2015
Filed publiclyJun 16, 2015
Amended 6 timesNewest Apr 7, 2016
Shares registered with an exchangeMar 28, 2016
Declared effective by the SECApr 7, 2016
Final prospectus, with the priceApr 7, 2016

From the cover of the final prospectus (424B4) filed Apr 7, 2016